Search hospitals
>
Rhode Island
>
Providence
Rhode Island Hospital
Claim this profile
Providence, Rhode Island 02903
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Leukemia
Conducts research for Solid Tumors
856 reported clinical trials
62 medical researchers
Summary
Rhode Island Hospital is a medical facility located in Providence, Rhode Island. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Leukemia, Solid Tumors and other specialties. Rhode Island Hospital is involved with conducting 856 clinical trials across 1,090 conditions. There are 62 research doctors associated with this hospital, such as Jennifer J. Welch, Bradley DeNardo, Benedito Carneiro, and Adam J. Olszewski.
Area of expertise
Cancer
Rhode Island Hospital has run 61 trials for Cancer. Some of their research focus areas include:
Breast Cancer
Rhode Island Hospital has run 54 trials for Breast Cancer. Some of their research focus areas include:
Top PIs
Jennifer J. Welch
Rhode Island Hospital
8 years of reported clinical research
Bradley DeNardo
Rhode Island Hospital
3 years of reported clinical research
Benedito Carneiro
Lifespan Cancer Institute
4 years of reported clinical research
Adam J. Olszewski
Rhode Island Hospital
4 years of reported clinical research
Clinical Trials running at Rhode Island Hospital
Breast Cancer
Lung Cancer
Breast cancer
Testicular cancer
Neuroblastoma
Insomnia
Brain Tumor
Non-Small Cell Lung Cancer
Cancer
Leukemia
Imlunestrant
for Early Breast Cancer
This trial is testing a new medication called imlunestrant to see if it works better than standard hormone treatments for certain breast cancer patients. The study focuses on patients with early-stage breast cancer that is estrogen receptor positive and HER2 negative, who have already been on hormone therapy for a period of time and are at high risk of their cancer returning. Imlunestrant works by blocking estrogen from helping cancer cells grow.
Recruiting
2 awards
Phase 3
6 criteria
Elacestrant
for Breast Cancer
The primary goal of this study is to evaluate the effectiveness of elacestrant versus standard endocrine therapy in participants with node-positive, Estrogen Receptor-positive (ER+), Human Epidermal Growth Factor-2 negative (HER2-) early breast cancer with high risk of recurrence.
Recruiting
2 awards
Phase 3
3 criteria
HER2-Targeted Therapy
for Breast Cancer
This phase III trial compares 6 months of human epidermal growth factor receptor 2 (HER2)-targeted therapy to 12 months of HER2-targeted therapy for the treatment of HER2-positive (+) breast cancer in patients that had a pathologic complete response (pCR) after preoperative (neoadjuvant) chemotherapy with trastuzumab. Trastuzumab and pertuzumab are monoclonal antibodies and forms of targeted therapy that attach to a receptor protein called HER2. HER2 is found on some cancer cells. When trastuzumab or pertuzumab attach to HER2, the signals that tell the cells to grow are blocked and the tumor cell may be marked for destruction by the body's immune system. Giving 6 months of HER2-targeted therapy may work better than giving 12 months for the treatment of HER2+ breast cancer in patients that had a pCR after neoadjuvant chemotherapy with trastuzumab.
Recruiting
2 awards
Phase 3
5 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Rhode Island Hospital?
Rhode Island Hospital is a medical facility located in Providence, Rhode Island. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Leukemia, Solid Tumors and other specialties. Rhode Island Hospital is involved with conducting 856 clinical trials across 1,090 conditions. There are 62 research doctors associated with this hospital, such as Jennifer J. Welch, Bradley DeNardo, Benedito Carneiro, and Adam J. Olszewski.
Where is Rhode Island Hospital located?
To reach Rhode Island Hospital in Providence, RI, take exit 20 from I-95 North and follow signs for Point Street. Turn left onto Friendship Street at the end of the ramp, then continue straight to 593 Eddy Street. Alternatively, GPS navigation services like MapQuest or Waze can provide real-time driving directions.
Who should I call to ask about financial aid or insurance network?
**Rhode Island Hospital Financial Assistance:** - For financial assistance, contact the Patient Financial Advocacy Program at (401) 788-1383. Assistance is available for uninsured Rhode Island residents meeting income criteria. - The Charity Care program aids uninsured, low-income residents who cannot access state, federal, or employer-sponsored health insurance. **Insurance Inquiries:** - For insurance questions or help understanding hospital bills, call customer service at 1-800-884-6966.
What insurance does Rhode Island Hospital accept?
Rhode Island Hospital accepts a wide range of insurance plans, including but not limited to Aetna, Blue Cross Blue Shield of Rhode Island, Harvard Pilgrim Health Care, and United HealthCare. Note that fees for personal physicians, specialists, and private duty nurses might not be included in the hospital's billing. Island Health also accepts various insurances, such as Aetna, Cigna, Kaiser Permanente, Medicare, and United Healthcare.
What awards or recognition has Rhode Island Hospital received?
Rhode Island Hospital, located in Providence, Rhode Island, is a distinguished facility recognized for its excellence in research and care. It has been named a Blue Distinction Center for both Cancer Care and Cardiac Care by the Blue Cross Blue Shield Association. The hospital is also notable for ranking 13th among independent hospitals in National Institutes of Health funding, receiving over $27 million annually, and has earned the Get With The Guidelines-Stroke Gold Plus award from the American Heart Association/American Stroke Association, including honors in Stroke Elite Plus, Stroke Advanced Therapy, and Type 2 Diabetes.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.